⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Figure S1 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer

Jamie M. Sperger Kyle T. Helzer Charlotte N. Stahlfeld Dawei Jiang Anupama Singh Katherine R. Kaufmann David J. Niles Erika Héninger Nicholas R. Rydzewski Liguo Wang Liewei Wang Rendong Yang Yanan Ren Jonathan W. Engle Peng Huang Christos E. Kyriakopoulos Susan F. Slovin Howard R. Soule Shuang G. Zhao Manish Kohli Scott T. Tagawa Weibo Cai Scott M. Dehm Joshua M. Lang

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Figure S1. Correlation of TACSTD2 with Prostate Cancer Cell Surface Markers.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sperger et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587522d58 https://doi.org/10.1158/1078-0432.27030463.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S2 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer2024
2Figure S3 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer2024
3Data from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer2024
4Figure S4 from Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer2024
5Supplementary Figure S1 from TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer2024

More related papers

Supplementary Figure S1 from TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer2024
Abstract 7225: TROP2 expression is abundant in primary and recurrent prostate cancer2026
TROP2 Is Uniformly Expressed in Primary Prostate Cancer but Frequently Reduced in Recurrent Disease2026